Literature DB >> 25713027

Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways.

Jesmond Dalli1, Sesquile Ramon1, Paul C Norris1, Romain A Colas1, Charles N Serhan2.   

Abstract

Local mediators orchestrate the host response to both sterile and infectious challenge and resolution. Recent evidence demonstrates that maresin sulfido-conjugates actively resolve acute inflammation and promote tissue regeneration. In this report, we investigated self-limited infectious exudates for novel bioactive chemical signals in tissue regeneration and resolution. By use of spleens from Escherichia coli infected mice, self-resolving infectious exudates, human spleens, and blood from patients with sepsis, we identified 2 new families of potent molecules. Characterization of their physical properties and isotope tracking demonstrated that the bioactive structures contained a docosahexaenoate backbone and sulfido-conjugated triene or tetraene double-bond systems. Activated human phagocytes converted 17-hydro(peroxy)-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid to these bioactive molecules. Regeneration of injured planaria was accelerated with nanomolar amounts of 16-glutathionyl, 17-hydroxy-4Z,7Z,10,12,14,19Z-docosahexaenoic acid and 16-cysteinylglycinyl, 17-hydroxy-4Z,7Z,10,12,14,19Z-docosahexaenoic acid (Protectin sulfido-conjugates) or 8-glutathionyl, 7,17-dihydroxy-4Z,9,11,13Z,15E,19Z-docosahexaenoic acid and 8-cysteinylglycinyl, 7,17-dihydroxy-4Z,9,11,13Z,15E,19Z-docosahexaenoic acid (Resolvin sulfido-conjugates). Each protectin and resolvin sulfido-conjugate dose dependently (0.1-10 nM) stimulated human macrophage bacterial phagocytosis, phagolysosomal acidification, and efferocytosis. Together, these results identify 2 novel pathways and provide evidence for structural elucidation of new resolution moduli. These resolvin and protectin conjugates identified in mice and human infected tissues control host responses promoting catabasis. © FASEB.

Entities:  

Keywords:  infection; inflammation; leukocytes; resolution

Mesh:

Substances:

Year:  2015        PMID: 25713027      PMCID: PMC4415017          DOI: 10.1096/fj.14-268441

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  27 in total

Review 1.  Purinergic signaling during inflammation.

Authors:  Holger K Eltzschig; Michail V Sitkovsky; Simon C Robson
Journal:  N Engl J Med       Date:  2012-12-13       Impact factor: 91.245

2.  Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis.

Authors:  Yoshitaka Taketomi; Noriko Ueno; Takumi Kojima; Hiroyasu Sato; Remi Murase; Kei Yamamoto; Satoshi Tanaka; Mariko Sakanaka; Masanori Nakamura; Yasumasa Nishito; Momoko Kawana; Naotomo Kambe; Kazutaka Ikeda; Ryo Taguchi; Satoshi Nakamizo; Kenji Kabashima; Michael H Gelb; Makoto Arita; Takehiko Yokomizo; Motonao Nakamura; Kikuko Watanabe; Hiroyuki Hirai; Masataka Nakamura; Yoshimichi Okayama; Chisei Ra; Kosuke Aritake; Yoshihiro Urade; Kazushi Morimoto; Yukihiko Sugimoto; Takao Shimizu; Shuh Narumiya; Shuntaro Hara; Makoto Murakami
Journal:  Nat Immunol       Date:  2013-04-28       Impact factor: 25.606

Review 3.  Chiral lipidomics of E-series resolvins: aspirin and the biosynthesis of novel mediators.

Authors:  Sungwhan F Oh; Thad W Vickery; Charles N Serhan
Journal:  Biochim Biophys Acta       Date:  2011-06-16

4.  Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain.

Authors:  Charles N Serhan; Jesmond Dalli; Sergey Karamnov; Alexander Choi; Chul-Kyu Park; Zhen-Zhong Xu; Ru-Rong Ji; Min Zhu; Nicos A Petasis
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

5.  Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection.

Authors:  Jesmond Dalli; Nan Chiang; Charles N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-16       Impact factor: 11.205

6.  Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators.

Authors:  Jesmond Dalli; Charles N Serhan
Journal:  Blood       Date:  2012-08-17       Impact factor: 22.113

Review 7.  Fresh approaches to anti-infective therapies.

Authors:  Carl Nathan
Journal:  Sci Transl Med       Date:  2012-06-27       Impact factor: 17.956

8.  Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation.

Authors:  Driss El Kebir; Per Gjorstrup; János G Filep
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

9.  Infection regulates pro-resolving mediators that lower antibiotic requirements.

Authors:  Nan Chiang; Gabrielle Fredman; Fredrik Bäckhed; Sungwhan F Oh; Thad Vickery; Birgitta A Schmidt; Charles N Serhan
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

Review 10.  Role of basic science in the development of new medicines: examples from the eicosanoid field.

Authors:  Bengt Samuelsson
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

View more
  48 in total

Review 1.  Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.

Authors:  Charles N Serhan
Journal:  FASEB J       Date:  2017-01-13       Impact factor: 5.191

Review 2.  Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.

Authors:  Charles N Serhan
Journal:  Mol Aspects Med       Date:  2017-03-03

Review 3.  New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.

Authors:  Charles N Serhan; Nan Chiang; Jesmond Dalli
Journal:  Mol Aspects Med       Date:  2017-09-01

Review 4.  Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.

Authors:  Nan Chiang; Charles N Serhan
Journal:  Mol Aspects Med       Date:  2017-03-31

Review 5.  Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.

Authors:  Milan Fiala; Gijs Kooij; Karen Wagner; Bruce Hammock; Matteo Pellegrini
Journal:  FASEB J       Date:  2017-04-18       Impact factor: 5.191

Review 6.  Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.

Authors:  Insha Zahoor; Shailendra Giri
Journal:  Clin Rev Allergy Immunol       Date:  2021-04       Impact factor: 8.667

Review 7.  Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Authors:  Martin D Rosenthal; Jayshil Patel; Kyle Staton; Robert G Martindale; Frederick A Moore; Gilbert R Upchurch
Journal:  Curr Gastroenterol Rep       Date:  2018-08-04

8.  First total synthesis of the pro-resolving lipid mediator 7(S),12(R),13(S)-Resolvin T2 and its 13(R)-epimer.

Authors:  Ana R Rodriguez; Bernd W Spur
Journal:  Tetrahedron Lett       Date:  2020-03-19       Impact factor: 2.415

Review 9.  Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.

Authors:  Brian E Sansbury; Matthew Spite
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

10.  Anti-inflammatory interventions-what has worked, not worked, and what may work in the future.

Authors:  Fatemeh Fattahi; Peter A Ward
Journal:  Transl Res       Date:  2015-08-14       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.